The potential for inappropriate medication prescribing in patients with Parkinson disease and dementia has been highlighted in a US study. Concurrent prescribing of a high potency anticholinergic medication and an acetylcholinesterase inhibitor (ACHEI) such as donepezil was common but should be a ‘never’ event due to their opposing pharmacologic effects, it found. And people with ...
Vigilance required for anticholinergic drugs in Parkinson patients
By Mardi Chapman
4 Oct 2018